Court Thins Misconduct Claims In Syringe Patent War
Faced with Becton Dickinson’s allegation that Retractable’s VanishPoint syringes infringe U.S. Patent Number 6,179,812, the syringe maker responded with an affirmative defense, claiming the patent-in-suit was unenforceable because the plaintiff committed inequitable conduct.
While Judge David Folsom of the U.S. District Court for the Eastern District of Texas held that three...
Already a subscriber? Click here to login